logo
Plus   Neg
Share
Email

Novartis Initiates Share Buyback Of Up To $2.5 Bln

Novartis (NVS) said that it is initiating a share buyback of up to $2.5 billion, reflecting its confidence in future growth and success of its pipeline.

The share buyback will be executed under the existing annual general meeting authority, starts immediately and will last into the first half of 2021, the company said in a statement.

The company noted that it commits to driving constant margin expansion and is on track to deliver $2 billion cost savings by year-end across Novartis Technical Operations and Novartis Business Services.

Novartis Technical Operations also has productivity programs in place that are set to further generate around $2 billion in cost reduction in the mid-term, the company said.

In the Pharmaceuticals business unit, the company has highlighted multiple mid- to late-stage assets with key milestones expected in 2021 and 2022.

In the Oncology business unit, the company has highlighting five mid- to late-stage assets with key milestones expected in 2021.

According to the company, Sandoz division continues to target sustained industry leadership, with growth driven primarily by biosimilars, based on a strong pipeline of more than 15 molecules, and a goal to achieve margins in the mid to high 20s range.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Electric Co. filed a lawsuit against Siemens Energy AG, accusing the German power distribution company of stealing trade secrets for gas turbines. Siemens Energy allegedly used the information to get at least nine contracts to supply gas turbines to public utilities, and also covered up improper business gains. Following a court ruling, the U.S. Food and Drug Administration postponed the effective date for tobacco manufacturing companies to display new health warnings on cigarette packets and in advertisements, by additional 90 days. The warnings with color images is to promote greater public understanding of the negative health consequences of smoking. JPMorgan Chase & Co (JPM) reported strong results in the fourth quarter of 2020, with net profit up 42% largely driven by credit reserve releases of $2.9 billion. The Group said it ended the year with a CET1 ratio of 13.1% and capital above $200 billion, providing with meaningful capacity to further...
Follow RTT